Recommendation for hormone replacement therapy in postmenopause

Česká verzia

Authors: Tomáš Fait ¹ ; J. Donát ²; J. Jeníček ^3,4; M. Burdová ⁵; J. Zahrádková ⁶; Peter Koliba ⁷
Authors place of work: Gynekologicko-porodnická klinika 1. LF UK a VFN Praha, přednosta prof. MUDr. A. Martan, DrSc. ¹; Porodnicko-gynekologická klinika Pardubické krajské nemocnice, přednosta doc. M. Košťál, CSc. ²; Centrum klimakterické medicíny, Lékařský dům Praha, a. s., vedoucí MUDr. J. Jeníček, CSc. ³; Gynekologicko-porodnická klinika 3. LF UK a FN KV Praha, přednosta doc. MUDr. B. Svoboda, CSc. ⁴; Soukromá gynekologická praxe, Praha ⁵; Centrum dětských odborných zdravotních služeb Brno, o. p., ředitelka MUDr. R. Svobodová ⁶; Gynartis s. r. o., vedoucí doc. MUDr. P. Koliba, CSc. ⁷
Published in the journal: Ceska Gynekol 2010; 75(2): 109-110

Zdroje

1. Birkhauser, MH., Panay, N., Archer, DF., et al. Updated recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric 2008, 11, 2, p. 108-124.

2. Caronico, M., Plu-Bureau, G., Conard, J., et al. Hormone therapy and venous thromboembolism among postmenopausal women. Circulation 2007, 115, p. 840-845.

3. Cauley, JA., Robbins, J., Chen, Z., et al. Effects of estrogen plus progestin on risk of fracture and BMD: WHI randomized trial. JAMA 2003, 290, p. 1729-1738.

4. Collins, P., Rosano, G., Casey, C., et al. Management of cardiovascular risk in the peri-menopausal women: a consensus statement of European cardiologist and Gynaecologist. Eur Heart J 2007, 28, p. 2028-2040.

5. Čepický, P., Bendová, M., Burdová, M., a kol. Doporučení k hormonální terapii a substituci perimenopauzy a postmenopauzy. Aktualizace 2005. Čes Gynek 2006, 71, 2, s. 150-152.

6. Ettinger, B., Ensrud, KE., Wallace, R., et al. Effects of ultra low-dose transdermal estradiol on bone mineral density. Obstet Gynecol 2004, 104, p. 443-451.

7. Grodstein, F., Manson, JE., Stampfer, MJ. Hormone replacement therapy and corony heart disease: the role of time since menopause and age at hormone initiation. J Womens Health 2006, 15, p. 35-44.

8. IMS Updated recommendations on postmenopausal hormone therapy. Climacteric 2007, 10, p. 181-194.

9. Lobo, RA. Menopause and stroke and the effects of hormone terapy. Climacteric 2007, 10 (Suppl 2), p. 27-31.

10. Rossow, JE., Prentice, RL., Manson, JE., et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007, 297, p. 1465-1477.

11. Salpeter, SR., Walsh, JM., Greyber, E., et al. Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. J Gen Intern Med 2004, 19, p. 791-804.

12. Utian, WH., Archer, DF., Bachmann, GA. Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause 2008,15, 4, p. 584-602.